<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-05-30" modified="2020-10-07" version="145">
<accession>Q86VB7</accession>
<accession>C9JIG2</accession>
<accession>Q07898</accession>
<accession>Q07899</accession>
<accession>Q07900</accession>
<accession>Q07901</accession>
<accession>Q2VLH7</accession>
<name>C163A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Scavenger receptor cysteine-rich type 1 protein M130</fullName>
</recommendedName>
<alternativeName>
<fullName>Hemoglobin scavenger receptor</fullName>
</alternativeName>
<cdAntigenName>CD163</cdAntigenName>
<component>
<recommendedName>
<fullName>Soluble CD163</fullName>
<shortName>sCD163</shortName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">CD163</name>
<name type="synonym">M130</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Eur. J. Immunol." volume="23" first="2320" last="2325">
<title>A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily.</title>
<authorList>
<person name="Law S.K.A."/>
<person name="Micklem K.J."/>
<person name="Shaw J.M."/>
<person name="Zhang X.-P."/>
<person name="Dong Y."/>
<person name="Willis A.C."/>
<person name="Mason D.Y."/>
</authorList>
<dbReference type="PubMed" id="8370408"/>
<dbReference type="DOI" id="10.1002/eji.1830230940"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4)</scope>
<scope>VARIANT VAL-342</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="260" first="466" last="474">
<title>Genomic organization and chromosomal localization of the human CD163 (M130) gene: a member of the scavenger receptor cysteine-rich superfamily.</title>
<authorList>
<person name="Ritter M."/>
<person name="Buechler C."/>
<person name="Langmann T."/>
<person name="Schmitz G."/>
</authorList>
<dbReference type="PubMed" id="10403791"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.0866"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT VAL-342</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-05" db="EMBL/GenBank/DDBJ databases">
<title>Scavenger receptor cd163 is a cell permissive factor for infection with porcine reproductive and respiratory syndrome viruses.</title>
<authorList>
<person name="Welch S.-K.W."/>
<person name="Calvert J.G."/>
<person name="Slade D.E."/>
<person name="Shields S.L."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>VARIANT VAL-342</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Nature" volume="440" first="346" last="351">
<title>The finished DNA sequence of human chromosome 12.</title>
<authorList>
<person name="Scherer S.E."/>
<person name="Muzny D.M."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Montgomery K.T."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Lovering R.C."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Draper H."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Havlak P."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Li L."/>
<person name="Li Z."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Plopper F.J.H."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Allen C.C."/>
<person name="Amin A.G."/>
<person name="Anyalebechi V."/>
<person name="Bailey M."/>
<person name="Barbaria J.A."/>
<person name="Bimage K.E."/>
<person name="Bryant N.P."/>
<person name="Burch P.E."/>
<person name="Burkett C.E."/>
<person name="Burrell K.L."/>
<person name="Calderon E."/>
<person name="Cardenas V."/>
<person name="Carter K."/>
<person name="Casias K."/>
<person name="Cavazos I."/>
<person name="Cavazos S.R."/>
<person name="Ceasar H."/>
<person name="Chacko J."/>
<person name="Chan S.N."/>
<person name="Chavez D."/>
<person name="Christopoulos C."/>
<person name="Chu J."/>
<person name="Cockrell R."/>
<person name="Cox C.D."/>
<person name="Dang M."/>
<person name="Dathorne S.R."/>
<person name="David R."/>
<person name="Davis C.M."/>
<person name="Davy-Carroll L."/>
<person name="Deshazo D.R."/>
<person name="Donlin J.E."/>
<person name="D'Souza L."/>
<person name="Eaves K.A."/>
<person name="Egan A."/>
<person name="Emery-Cohen A.J."/>
<person name="Escotto M."/>
<person name="Flagg N."/>
<person name="Forbes L.D."/>
<person name="Gabisi A.M."/>
<person name="Garza M."/>
<person name="Hamilton C."/>
<person name="Henderson N."/>
<person name="Hernandez O."/>
<person name="Hines S."/>
<person name="Hogues M.E."/>
<person name="Huang M."/>
<person name="Idlebird D.G."/>
<person name="Johnson R."/>
<person name="Jolivet A."/>
<person name="Jones S."/>
<person name="Kagan R."/>
<person name="King L.M."/>
<person name="Leal B."/>
<person name="Lebow H."/>
<person name="Lee S."/>
<person name="LeVan J.M."/>
<person name="Lewis L.C."/>
<person name="London P."/>
<person name="Lorensuhewa L.M."/>
<person name="Loulseged H."/>
<person name="Lovett D.A."/>
<person name="Lucier A."/>
<person name="Lucier R.L."/>
<person name="Ma J."/>
<person name="Madu R.C."/>
<person name="Mapua P."/>
<person name="Martindale A.D."/>
<person name="Martinez E."/>
<person name="Massey E."/>
<person name="Mawhiney S."/>
<person name="Meador M.G."/>
<person name="Mendez S."/>
<person name="Mercado C."/>
<person name="Mercado I.C."/>
<person name="Merritt C.E."/>
<person name="Miner Z.L."/>
<person name="Minja E."/>
<person name="Mitchell T."/>
<person name="Mohabbat F."/>
<person name="Mohabbat K."/>
<person name="Montgomery B."/>
<person name="Moore N."/>
<person name="Morris S."/>
<person name="Munidasa M."/>
<person name="Ngo R.N."/>
<person name="Nguyen N.B."/>
<person name="Nickerson E."/>
<person name="Nwaokelemeh O.O."/>
<person name="Nwokenkwo S."/>
<person name="Obregon M."/>
<person name="Oguh M."/>
<person name="Oragunye N."/>
<person name="Oviedo R.J."/>
<person name="Parish B.J."/>
<person name="Parker D.N."/>
<person name="Parrish J."/>
<person name="Parks K.L."/>
<person name="Paul H.A."/>
<person name="Payton B.A."/>
<person name="Perez A."/>
<person name="Perrin W."/>
<person name="Pickens A."/>
<person name="Primus E.L."/>
<person name="Pu L.-L."/>
<person name="Puazo M."/>
<person name="Quiles M.M."/>
<person name="Quiroz J.B."/>
<person name="Rabata D."/>
<person name="Reeves K."/>
<person name="Ruiz S.J."/>
<person name="Shao H."/>
<person name="Sisson I."/>
<person name="Sonaike T."/>
<person name="Sorelle R.P."/>
<person name="Sutton A.E."/>
<person name="Svatek A.F."/>
<person name="Svetz L.A."/>
<person name="Tamerisa K.S."/>
<person name="Taylor T.R."/>
<person name="Teague B."/>
<person name="Thomas N."/>
<person name="Thorn R.D."/>
<person name="Trejos Z.Y."/>
<person name="Trevino B.K."/>
<person name="Ukegbu O.N."/>
<person name="Urban J.B."/>
<person name="Vasquez L.I."/>
<person name="Vera V.A."/>
<person name="Villasana D.M."/>
<person name="Wang L."/>
<person name="Ward-Moore S."/>
<person name="Warren J.T."/>
<person name="Wei X."/>
<person name="White F."/>
<person name="Williamson A.L."/>
<person name="Wleczyk R."/>
<person name="Wooden H.S."/>
<person name="Wooden S.H."/>
<person name="Yen J."/>
<person name="Yoon L."/>
<person name="Yoon V."/>
<person name="Zorrilla S.E."/>
<person name="Nelson D."/>
<person name="Kucherlapati R."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16541075"/>
<dbReference type="DOI" id="10.1038/nature04569"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT VAL-342</scope>
<source>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="256" first="110" last="113">
<title>Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family.</title>
<authorList>
<person name="Droste A."/>
<person name="Sorg C."/>
<person name="Hogger P."/>
</authorList>
<dbReference type="PubMed" id="10066432"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.0294"/>
</citation>
<scope>CLEAVAGE</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1999" name="J. Leukoc. Biol." volume="66" first="858" last="866">
<title>Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation.</title>
<authorList>
<person name="Van den Heuvel M.M."/>
<person name="Tensen C.P."/>
<person name="van As J.H."/>
<person name="Van den Berg T.K."/>
<person name="Fluitsma D.M."/>
<person name="Dijkstra C.D."/>
<person name="Dopp E.A."/>
<person name="Droste A."/>
<person name="Van Gaalen F.A."/>
<person name="Sorg C."/>
<person name="Hoegger P."/>
<person name="Beelen R.H.J."/>
</authorList>
<dbReference type="PubMed" id="10577520"/>
<dbReference type="DOI" id="10.1002/jlb.66.5.858"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="J. Leukoc. Biol." volume="67" first="97" last="103">
<title>Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli.</title>
<authorList>
<person name="Buechler C."/>
<person name="Ritter M."/>
<person name="Orso E."/>
<person name="Langmann T."/>
<person name="Klucken J."/>
<person name="Schmitz G."/>
</authorList>
<dbReference type="PubMed" id="10648003"/>
<dbReference type="DOI" id="10.1002/jlb.67.1.97"/>
</citation>
<scope>INDUCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="Eur. J. Immunol." volume="31" first="999" last="1009">
<title>Interaction of CD163 with the regulatory subunit of casein kinase II (CKII) and dependence of CD163 signaling on CKII and protein kinase C.</title>
<authorList>
<person name="Ritter M."/>
<person name="Buechler C."/>
<person name="Kapinsky M."/>
<person name="Schmitz G."/>
</authorList>
<dbReference type="PubMed" id="11298324"/>
<dbReference type="DOI" id="10.1002/1521-4141(200104)31:4&lt;999::aid-immu999&gt;3.0.co;2-r"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF THR-1072 AND SER-1084</scope>
<scope>INTERACTION WITH CSNK2B</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="Nature" volume="409" first="198" last="201">
<title>Identification of the haemoglobin scavenger receptor.</title>
<authorList>
<person name="Kristiansen M."/>
<person name="Graversen J.H."/>
<person name="Jacobsen C."/>
<person name="Sonne O."/>
<person name="Hoffman H.-J."/>
<person name="Law S.K.A."/>
<person name="Moestrup S.K."/>
</authorList>
<dbReference type="PubMed" id="11196644"/>
<dbReference type="DOI" id="10.1038/35051594"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="Clin. Exp. Immunol." volume="130" first="156" last="161">
<title>Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3.</title>
<authorList>
<person name="Matsushita N."/>
<person name="Kashiwagi M."/>
<person name="Wait R."/>
<person name="Nagayoshi R."/>
<person name="Nakamura M."/>
<person name="Matsuda T."/>
<person name="Hogger P."/>
<person name="Guyre P.M."/>
<person name="Nagase H."/>
<person name="Matsuyama T."/>
</authorList>
<dbReference type="PubMed" id="12296867"/>
<dbReference type="DOI" id="10.1046/j.1365-2249.2002.01963.x"/>
</citation>
<scope>CLEAVAGE</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="FEBS Lett." volume="526" first="93" last="96">
<title>Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect.</title>
<authorList>
<person name="Frings W."/>
<person name="Dreier J."/>
<person name="Sorg C."/>
</authorList>
<dbReference type="PubMed" id="12208511"/>
<dbReference type="DOI" id="10.1016/s0014-5793(02)03142-3"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="J. Leukoc. Biol." volume="72" first="711" last="717">
<title>Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163.</title>
<authorList>
<person name="Hintz K.A."/>
<person name="Rassias A.J."/>
<person name="Wardwell K."/>
<person name="Moss M.L."/>
<person name="Morganelli P.M."/>
<person name="Pioli P.A."/>
<person name="Givan A.L."/>
<person name="Wallace P.K."/>
<person name="Yeager M.P."/>
<person name="Guyre P.M."/>
</authorList>
<dbReference type="PubMed" id="12377940"/>
</citation>
<scope>MISCELLANEOUS</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Ann. Med." volume="36" first="347" last="354">
<title>CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response.</title>
<authorList>
<person name="Moestrup S.K."/>
<person name="Moller H.J."/>
</authorList>
<dbReference type="PubMed" id="15478309"/>
<dbReference type="DOI" id="10.1080/07853890410033171"/>
</citation>
<scope>RELEVANCE AS DISEASE MARKER IN INFLAMMATORY CONDITIONS</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="51561" last="51567">
<title>Molecular characterization of the haptoglobin.hemoglobin receptor CD163. Ligand binding properties of the scavenger receptor cysteine-rich domain region.</title>
<authorList>
<person name="Madsen M."/>
<person name="Moller H.J."/>
<person name="Nielsen M.J."/>
<person name="Jacobsen C."/>
<person name="Graversen J.H."/>
<person name="van den Berg T."/>
<person name="Moestrup S.K."/>
</authorList>
<dbReference type="PubMed" id="15448162"/>
<dbReference type="DOI" id="10.1074/jbc.m409629200"/>
</citation>
<scope>DOMAIN</scope>
<scope>CLEAVAGE SITES</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="J. Leukoc. Biol." volume="76" first="271" last="277">
<title>Cross-linking of FcgammaR triggers shedding of the hemoglobin-haptoglobin scavenger receptor CD163.</title>
<authorList>
<person name="Sulahian T.H."/>
<person name="Pioli P.A."/>
<person name="Wardwell K."/>
<person name="Guyre P.M."/>
</authorList>
<dbReference type="PubMed" id="15075364"/>
<dbReference type="DOI" id="10.1189/jlb.1003523"/>
</citation>
<scope>CLEAVAGE</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-105</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="J. Leukoc. Biol." volume="79" first="837" last="845">
<title>The macrophage scavenger receptor CD163: endocytic properties of cytoplasmic tail variants.</title>
<authorList>
<person name="Nielsen M.J."/>
<person name="Madsen M."/>
<person name="Moller H.J."/>
<person name="Moestrup S.K."/>
</authorList>
<dbReference type="PubMed" id="16434690"/>
<dbReference type="DOI" id="10.1189/jlb.1005602"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF TYR-1096</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-105; ASN-140; ASN-767 AND ASN-1027</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="913" last="923">
<title>A strategy for precise and large scale identification of core fucosylated glycoproteins.</title>
<authorList>
<person name="Jia W."/>
<person name="Lu Z."/>
<person name="Fu Y."/>
<person name="Wang H.P."/>
<person name="Wang L.H."/>
<person name="Chi H."/>
<person name="Yuan Z.F."/>
<person name="Zheng Z.B."/>
<person name="Song L.N."/>
<person name="Han H.H."/>
<person name="Liang Y.M."/>
<person name="Wang J.L."/>
<person name="Cai Y."/>
<person name="Zhang Y.K."/>
<person name="Deng Y.L."/>
<person name="Ying W.T."/>
<person name="He S.M."/>
<person name="Qian X.H."/>
</authorList>
<dbReference type="PubMed" id="19139490"/>
<dbReference type="DOI" id="10.1074/mcp.m800504-mcp200"/>
</citation>
<scope>GLYCOSYLATION AT ASN-105</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<comment type="function">
<text>Acute phase-regulated receptor involved in clearance and endocytosis of hemoglobin/haptoglobin complexes by macrophages and may thereby protect tissues from free hemoglobin-mediated oxidative damage. May play a role in the uptake and recycling of iron, via endocytosis of hemoglobin/haptoglobin and subsequent breakdown of heme. Binds hemoglobin/haptoglobin complexes in a calcium-dependent and pH-dependent manner. Exhibits a higher affinity for complexes of hemoglobin and multimeric haptoglobin of HP*1F phenotype than for complexes of hemoglobin and dimeric haptoglobin of HP*1S phenotype. Induces a cascade of intracellular signals that involves tyrosine kinase-dependent calcium mobilization, inositol triphosphate production and secretion of IL6 and CSF1. Isoform 3 exhibits the higher capacity for ligand endocytosis and the more pronounced surface expression when expressed in cells.</text>
</comment>
<comment type="function">
<text>After shedding, the soluble form (sCD163) may play an anti-inflammatory role, and may be a valuable diagnostic parameter for monitoring macrophage activation in inflammatory conditions.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="7">2.0 nM for hemoglobin/haptoglobin of HP*1S phenotype</KM>
<KM evidence="7">0.2 nM for hemoglobin/haptoglobin of HP*1F phenotype</KM>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="8">Interacts with CSNK2B.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2808455">
<id>Q86VB7</id>
</interactant>
<interactant intactId="EBI-2869867">
<id>P12314</id>
<label>FCGR1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<molecule>Soluble CD163</molecule>
<subcellularLocation>
<location evidence="9">Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="5 6">Cell membrane</location>
<topology evidence="5 6">Single-pass type I membrane protein</topology>
</subcellularLocation>
<text>Isoform 1 and isoform 2 show a lower surface expression when expressed in cells.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q86VB7-1</id>
<name>1</name>
<name>Long tail variant 1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q86VB7-2</id>
<name>2</name>
<name>Long tail variant 2</name>
<sequence type="described" ref="VSP_019014"/>
</isoform>
<isoform>
<id>Q86VB7-3</id>
<name>3</name>
<name>Short tail variant</name>
<sequence type="described" ref="VSP_019015"/>
</isoform>
<isoform>
<id>Q86VB7-4</id>
<name>4</name>
<sequence type="described" ref="VSP_019013 VSP_019015"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="5 7 14">Expressed in monocytes and mature macrophages such as Kupffer cells in the liver, red pulp macrophages in the spleen, cortical macrophages in the thymus, resident bone marrow macrophages and meningeal macrophages of the central nervous system. Expressed also in blood. Isoform 1 is the lowest abundant in the blood. Isoform 2 is the lowest abundant in the liver and the spleen. Isoform 3 is the predominant isoform detected in the blood.</text>
</comment>
<comment type="induction">
<text evidence="5 6">Induced by anti-inflammatory mediators such as glucocorticoids, interleukin-6/IL6 and interleukin-10/IL10; suppressed by proinflammatory mediators like bacterial lipopolysaccharides (LPS), IFNG/IFN-gamma and TNF.</text>
</comment>
<comment type="domain">
<text evidence="11">The SRCR domain 3 mediates calcium-sensitive interaction with hemoglobin/haptoglobin complexes.</text>
</comment>
<comment type="PTM">
<text evidence="3 9 10 11">A soluble form (sCD163) is produced by proteolytic shedding which can be induced by lipopolysaccharide, phorbol ester and Fc region of immunoglobulin gamma. This cleavage is dependent on protein kinase C and tyrosine kinases and can be blocked by protease inhibitors. The shedding is inhibited by the tissue inhibitor of metalloproteinase TIMP3, and thus probably induced by membrane-bound metalloproteinases ADAMs.</text>
</comment>
<comment type="PTM">
<text evidence="22">Phosphorylated.</text>
</comment>
<comment type="miscellaneous">
<text>Intravenous lipopolysaccharide (LPS) produces a rapid rise of sCD163 in plasma of patient as it induces metalloproteinase-mediated shedding from monocytes surface. Long-term LPS infusion finally increases expression of the membrane-bound form on circulating monocytes.</text>
</comment>
<comment type="miscellaneous">
<text>The soluble form (sCD163) in plasma is a novel parameter in diseases affecting macrophage function and monocyte/macrophage load in the body. The concentration of sCD163 is probably reflecting the number of macrophages of the 'alternative macrophage activation' phenotype with a high CD163 expression playing a major role in dampening the inflammatory response and scavenging components of damaged cells. This has initiated a number of clinical studies for evaluation of sCD163 as a disease marker in inflammatory conditions e.g. infection, autoimmune disease, transplantation, atherosclerosis and cancer.</text>
</comment>
<comment type="caution">
<text evidence="21">It is uncertain whether Met-1 or Met-6 is the initiator.</text>
</comment>
<comment type="sequence caution" evidence="21">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAA80541" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="21">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAA80542" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="21">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAA80543" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="21">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAA80544" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="21">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAB45233" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<dbReference type="EMBL" id="Z22968">
<property type="protein sequence ID" value="CAA80541.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z22969">
<property type="protein sequence ID" value="CAA80542.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z22970">
<property type="protein sequence ID" value="CAA80543.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z22971">
<property type="protein sequence ID" value="CAA80544.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18388">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18389">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18390">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18391">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18392">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18393">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18394">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18395">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18396">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18397">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18398">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18399">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18400">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18401">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18402">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y18403">
<property type="protein sequence ID" value="CAB45233.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ058615">
<property type="protein sequence ID" value="AAY99762.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC131206">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC051281">
<property type="protein sequence ID" value="AAH51281.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53742.1">
<molecule id="Q86VB7-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8578.1">
<molecule id="Q86VB7-1"/>
</dbReference>
<dbReference type="PIR" id="I38004">
<property type="entry name" value="I38004"/>
</dbReference>
<dbReference type="PIR" id="I38005">
<property type="entry name" value="I38005"/>
</dbReference>
<dbReference type="PIR" id="I38006">
<property type="entry name" value="I38006"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004235.4">
<molecule id="Q86VB7-1"/>
<property type="nucleotide sequence ID" value="NM_004244.5"/>
</dbReference>
<dbReference type="RefSeq" id="NP_981961.2">
<molecule id="Q86VB7-3"/>
<property type="nucleotide sequence ID" value="NM_203416.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016875720.1">
<property type="nucleotide sequence ID" value="XM_017020231.1"/>
</dbReference>
<dbReference type="SMR" id="Q86VB7"/>
<dbReference type="BioGRID" id="114741">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="IntAct" id="Q86VB7">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000352071"/>
<dbReference type="DrugBank" id="DB05389">
<property type="generic name" value="Tetrachlorodecaoxide"/>
</dbReference>
<dbReference type="GlyConnect" id="1723">
<property type="glycosylation" value="14 N-Linked glycans (6 sites)"/>
</dbReference>
<dbReference type="GlyGen" id="Q86VB7">
<property type="glycosylation" value="11 sites, 2 O-linked glycans (3 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="Q86VB7"/>
<dbReference type="PhosphoSitePlus" id="Q86VB7"/>
<dbReference type="BioMuta" id="CD163"/>
<dbReference type="DMDM" id="313104083"/>
<dbReference type="jPOST" id="Q86VB7"/>
<dbReference type="MassIVE" id="Q86VB7"/>
<dbReference type="PaxDb" id="Q86VB7"/>
<dbReference type="PeptideAtlas" id="Q86VB7"/>
<dbReference type="PRIDE" id="Q86VB7"/>
<dbReference type="ProteomicsDB" id="69982">
<molecule id="Q86VB7-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="69983">
<molecule id="Q86VB7-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="69984">
<molecule id="Q86VB7-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="69985">
<molecule id="Q86VB7-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="3721">
<property type="antibodies" value="1461 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000359156">
<molecule id="Q86VB7-1"/>
<property type="protein sequence ID" value="ENSP00000352071"/>
<property type="gene ID" value="ENSG00000177575"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000432237">
<molecule id="Q86VB7-3"/>
<property type="protein sequence ID" value="ENSP00000403885"/>
<property type="gene ID" value="ENSG00000177575"/>
</dbReference>
<dbReference type="GeneID" id="9332"/>
<dbReference type="KEGG" id="hsa:9332"/>
<dbReference type="UCSC" id="uc001qsz.4">
<molecule id="Q86VB7-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9332"/>
<dbReference type="DisGeNET" id="9332"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000177575.12"/>
<dbReference type="GeneCards" id="CD163"/>
<dbReference type="HGNC" id="HGNC:1631">
<property type="gene designation" value="CD163"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000177575">
<property type="expression patterns" value="Tissue enhanced (lymphoid)"/>
</dbReference>
<dbReference type="MIM" id="605545">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q86VB7"/>
<dbReference type="OpenTargets" id="ENSG00000177575"/>
<dbReference type="PharmGKB" id="PA26190"/>
<dbReference type="eggNOG" id="ENOG502QQ5W">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155987"/>
<dbReference type="HOGENOM" id="CLU_002555_0_1_1"/>
<dbReference type="InParanoid" id="Q86VB7"/>
<dbReference type="KO" id="K06545"/>
<dbReference type="OMA" id="SGQVWRH"/>
<dbReference type="OrthoDB" id="1095487at2759"/>
<dbReference type="PhylomeDB" id="Q86VB7"/>
<dbReference type="TreeFam" id="TF329295"/>
<dbReference type="PathwayCommons" id="Q86VB7"/>
<dbReference type="Reactome" id="R-HSA-2168880">
<property type="pathway name" value="Scavenging of heme from plasma"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9662834">
<property type="pathway name" value="CD163 mediating an anti-inflammatory response"/>
</dbReference>
<dbReference type="SIGNOR" id="Q86VB7"/>
<dbReference type="BioGRID-ORCS" id="9332">
<property type="hits" value="5 hits in 865 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CD163">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="CD163"/>
<dbReference type="GenomeRNAi" id="9332"/>
<dbReference type="Pharos" id="Q86VB7">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q86VB7"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="RNAct" id="Q86VB7">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000177575">
<property type="expression patterns" value="Expressed in esophagus and 204 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q86VB7">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q86VB7">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030666">
<property type="term" value="C:endocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005044">
<property type="term" value="F:scavenger receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006953">
<property type="term" value="P:acute-phase response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006898">
<property type="term" value="P:receptor-mediated endocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="3.10.250.10">
<property type="match status" value="9"/>
</dbReference>
<dbReference type="InterPro" id="IPR001190">
<property type="entry name" value="SRCR"/>
</dbReference>
<dbReference type="InterPro" id="IPR017448">
<property type="entry name" value="SRCR-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036772">
<property type="entry name" value="SRCR-like_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00530">
<property type="entry name" value="SRCR"/>
<property type="match status" value="9"/>
</dbReference>
<dbReference type="PRINTS" id="PR00258">
<property type="entry name" value="SPERACTRCPTR"/>
</dbReference>
<dbReference type="SMART" id="SM00202">
<property type="entry name" value="SR"/>
<property type="match status" value="9"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56487">
<property type="entry name" value="SSF56487"/>
<property type="match status" value="9"/>
</dbReference>
<dbReference type="PROSITE" id="PS00420">
<property type="entry name" value="SRCR_1"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS50287">
<property type="entry name" value="SRCR_2"/>
<property type="match status" value="9"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0011">Acute phase</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="1">
<location>
<begin position="1"/>
<end position="41"/>
</location>
</feature>
<feature type="chain" description="Scavenger receptor cysteine-rich type 1 protein M130" id="PRO_0000238938">
<location>
<begin position="42"/>
<end position="1156"/>
</location>
</feature>
<feature type="chain" description="Soluble CD163" id="PRO_0000238939">
<location>
<begin position="42"/>
<end status="unknown"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="1">
<location>
<begin position="42"/>
<end position="1050"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="1">
<location>
<begin position="1051"/>
<end position="1071"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="1">
<location>
<begin position="1072"/>
<end position="1156"/>
</location>
</feature>
<feature type="domain" description="SRCR 1" evidence="2">
<location>
<begin position="51"/>
<end position="152"/>
</location>
</feature>
<feature type="domain" description="SRCR 2" evidence="2">
<location>
<begin position="159"/>
<end position="259"/>
</location>
</feature>
<feature type="domain" description="SRCR 3" evidence="2">
<location>
<begin position="266"/>
<end position="366"/>
</location>
</feature>
<feature type="domain" description="SRCR 4" evidence="2">
<location>
<begin position="373"/>
<end position="473"/>
</location>
</feature>
<feature type="domain" description="SRCR 5" evidence="2">
<location>
<begin position="478"/>
<end position="578"/>
</location>
</feature>
<feature type="domain" description="SRCR 6" evidence="2">
<location>
<begin position="583"/>
<end position="683"/>
</location>
</feature>
<feature type="domain" description="SRCR 7" evidence="2">
<location>
<begin position="719"/>
<end position="819"/>
</location>
</feature>
<feature type="domain" description="SRCR 8" evidence="2">
<location>
<begin position="824"/>
<end position="926"/>
</location>
</feature>
<feature type="domain" description="SRCR 9" evidence="2">
<location>
<begin position="929"/>
<end position="1029"/>
</location>
</feature>
<feature type="short sequence motif" description="Internalization signal">
<location>
<begin position="1096"/>
<end position="1099"/>
</location>
</feature>
<feature type="site" description="Cleavage; in calcium-free condition">
<location>
<begin position="269"/>
<end position="270"/>
</location>
</feature>
<feature type="site" description="Cleavage; in calcium-free condition">
<location>
<begin position="281"/>
<end position="282"/>
</location>
</feature>
<feature type="site" description="Cleavage; in calcium-free condition">
<location>
<begin position="333"/>
<end position="334"/>
</location>
</feature>
<feature type="site" description="Cleavage; in calcium-free condition">
<location>
<begin position="360"/>
<end position="361"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine" evidence="13 15 16">
<location>
<position position="105"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="140"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="767"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="1027"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="76"/>
<end position="141"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="89"/>
<end position="151"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="120"/>
<end position="130"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="184"/>
<end position="248"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="197"/>
<end position="258"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="228"/>
<end position="238"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="291"/>
<end position="355"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="304"/>
<end position="365"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="335"/>
<end position="345"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="398"/>
<end position="462"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="411"/>
<end position="472"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="442"/>
<end position="452"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="503"/>
<end position="567"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="516"/>
<end position="577"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="547"/>
<end position="557"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="608"/>
<end position="672"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="621"/>
<end position="682"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="652"/>
<end position="662"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="744"/>
<end position="808"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="757"/>
<end position="818"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="788"/>
<end position="798"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="864"/>
<end position="925"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="895"/>
<end position="905"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="954"/>
<end position="1018"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="967"/>
<end position="1028"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="998"/>
<end position="1008"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_019013" evidence="19">
<original>R</original>
<variation>SKTQKTSLIGSYTVKGTGLGSHSCLFLKPCLLPG</variation>
<location>
<position position="579"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_019014" evidence="19">
<original>ENSHESADFSAAELISVSKFLPISGMEKEAILSHTEKENGNL</original>
<variation>GLWVLGGSIAQGFRSVAAVEAQTFYFDKQLKKSKNVIGSLDAYNGQE</variation>
<location>
<begin position="1115"/>
<end position="1156"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 4." id="VSP_019015" evidence="19 20">
<original>ENSHESADFSAAELISVSKFLPISGMEKEAILSHTEKENGNL</original>
<variation>GGHSEPH</variation>
<location>
<begin position="1115"/>
<end position="1156"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4883263." id="VAR_026574" evidence="4 12 17 18">
<original>I</original>
<variation>V</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired phosphorylation by PRKCA." evidence="8">
<original>T</original>
<variation>A</variation>
<location>
<position position="1072"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired phosphorylation by PRKCA." evidence="8">
<original>S</original>
<variation>A</variation>
<location>
<position position="1084"/>
</location>
</feature>
<feature type="mutagenesis site" description="Massive decrease of endocytotic activity." evidence="14">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1096"/>
</location>
</feature>
<evidence key="1" type="ECO:0000255"/>
<evidence key="2" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00196"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10066432"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10403791"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10577520"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10648003"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11196644"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11298324"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12296867"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15075364"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15448162"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16434690"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19139490"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8370408"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="19" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8370408"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="21" type="ECO:0000305"/>
<evidence key="22" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11298324"/>
</source>
</evidence>
<sequence length="1156" mass="125451" checksum="57B49F76DA6C96EB" modified="2010-11-30" version="2" precursor="true">MSKLRMVLLEDSGSADFRRHFVNLSPFTITVVLLLSACFVTSSLGGTDKELRLVDGENKCSGRVEVKVQEEWGTVCNNGWSMEAVSVICNQLGCPTAIKAPGWANSSAGSGRIWMDHVSCRGNESALWDCKHDGWGKHSNCTHQQDAGVTCSDGSNLEMRLTRGGNMCSGRIEIKFQGRWGTVCDDNFNIDHASVICRQLECGSAVSFSGSSNFGEGSGPIWFDDLICNGNESALWNCKHQGWGKHNCDHAEDAGVICSKGADLSLRLVDGVTECSGRLEVRFQGEWGTICDDGWDSYDAAVACKQLGCPTAVTAIGRVNASKGFGHIWLDSVSCQGHEPAIWQCKHHEWGKHYCNHNEDAGVTCSDGSDLELRLRGGGSRCAGTVEVEIQRLLGKVCDRGWGLKEADVVCRQLGCGSALKTSYQVYSKIQATNTWLFLSSCNGNETSLWDCKNWQWGGLTCDHYEEAKITCSAHREPRLVGGDIPCSGRVEVKHGDTWGSICDSDFSLEAASVLCRELQCGTVVSILGGAHFGEGNGQIWAEEFQCEGHESHLSLCPVAPRPEGTCSHSRDVGVVCSRYTEIRLVNGKTPCEGRVELKTLGAWGSLCNSHWDIEDAHVLCQQLKCGVALSTPGGARFGKGNGQIWRHMFHCTGTEQHMGDCPVTALGASLCPSEQVASVICSGNQSQTLSSCNSSSLGPTRPTIPEESAVACIESGQLRLVNGGGRCAGRVEIYHEGSWGTICDDSWDLSDAHVVCRQLGCGEAINATGSAHFGEGTGPIWLDEMKCNGKESRIWQCHSHGWGQQNCRHKEDAGVICSEFMSLRLTSEASREACAGRLEVFYNGAWGTVGKSSMSETTVGVVCRQLGCADKGKINPASLDKAMSIPMWVDNVQCPKGPDTLWQCPSSPWEKRLASPSEETWITCDNKIRLQEGPTSCSGRVEIWHGGSWGTVCDDSWDLDDAQVVCQQLGCGPALKAFKEAEFGQGTGPIWLNEVKCKGNESSLWDCPARRWGHSECGHKEDAAVNCTDISVQKTPQKATTGRSSRQSSFIAVGILGVVLLAIFVALFFLTKKRRQRQRLAVSSRGENLVHQIQYREMNSCLNADDLDLMNSSENSHESADFSAAELISVSKFLPISGMEKEAILSHTEKENGNL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

